Author:
Yang Wookjin,Kang Dong-Wan,Kim Jeong-Min,Jung Keun-Hwa,Lee Seung-Hoon
Abstract
AbstractRecognizing the lesion pattern of antiphospholipid antibody-related stroke (aPL-stroke) may contribute to establishing the cause in patients with cryptogenic stroke. We aimed to describe the neuroimaging features of aPL-stroke compared with atrial fibrillation-related stroke (AF-stroke), a major hidden cause of cryptogenic stroke. Using a prospective stroke registry, we identified consecutive aPL- and AF-stroke patients without other potential causes of stroke. Neuroimaging features based on diffusion-weighted imaging and angiographic findings at admission were compared. A total of 56 and 333 patients were included in the aPL- and AF-stroke groups, respectively. aPL-stroke patients more often presented with single small lesions (aPL-stroke, 30.4% vs. AF-stroke, 7.5%, p < 0.001), while the predominant pattern in AF-stroke patients was large territorial lesions (26.8% vs. 56.5%, p < 0.001). aPL-stroke patients had smaller infarct volume (1.58 mL [0.45; 9.41] vs. 11.32 mL [2.82; 33.08], p < 0.001) and less experience of relevant artery occlusion (17.9% vs. 54.7%, p < 0.001). The proportion of multi-territory lesions, an embolic pattern, was similar between the two groups (28.6% vs. 22.8%, p = 0.44). In comparison only including patients with multi-territory lesions as well, aPL-stroke patients showed small lesion dominance and smaller infarct volume. Multivariate analyses showed independent associations between mild neuroimaging features (small lesion prevalence, smaller infarct volume, and absence of relevant artery occlusion) and aPL-stroke. Patterns of small lesion prevalence, small infarct volume, and absence of relevant artery occlusion were suggestive of aPL-stroke rather than AF-stroke. Cryptogenic stroke patients with such neuroimaging features may benefit from aPL testing for a precise diagnosis.
Funder
National Research Foundation of Korea
Korea Health Industry Development Institute
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 21, 1268–1273 (1990).
2. Levine, S. R., Deegan, M. J., Futrell, N. & Welch, K. M. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 40, 1181–1189 (1990).
3. Provenzale, J. M., Barboriak, D. P., Allen, N. B. & Ortel, T. L. Antiphospholipid antibodies: Findings at arteriography. AJNR Am. J. Neuroradiol. 19, 611–616 (1998).
4. Provenzale, J. M., Barboriak, D. P., Allen, N. B. & Ortel, T. L. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am. J. Roentgenol. 167, 1573–1578 (1996).
5. Lu, Y. et al. Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke: A meta-analysis. Neurol. Sci. 42, 4139–4148 (2021).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献